Page 8 - Veena Mani

Government to establish 4,000 dialysis centres across the country, says J P Nadda

The government is also working on a National Health Policy that focuses on providing free basic healthcare for people below the poverty line

Aviva insurance to focus on partnership with digital companies: Trevor Bull

He also adds that demonetisation will help the insurance space in the long and medium term

Panel suggests one-time licensing for drugs

At present, the renewal of licences for each formulation rests with state regulators and is around 3 years

Booster dose for bulk drug production, government invites EoI from companies

The project aims to set up common facilities for companies and upgrade any existing one

No tests were done on soft drinks: NTH

Contrary to health ministry statement, it appears entity named as having tested soft drink brands for toxins, and found indications, had not done so

Govt invites domestic pharma firms to set up bulk drug clusters

Govt will fund up to 70% of project cost, subject to a cap of Rs 20 crore to set up a cluster on PPP basis

200 'high-risk' drug firms come under Indian regulator lens

Centre, states jointly assess drug manufacturers' facilities

We should have 5 million customers by 2020: David Mcmillan, Aviva Europe

Aviva India is a life insurance joint venture between the UK's Aviva Plc and the Dabur group

Domestic stent maker SMT fights perception with new trial

Move comes at a time when MNCs are advocating differential pricing under NLEM

No Indian Pharma company in world Access to Medicine Index

GSK, J&J, Novartis, Merck are among top 20 firms working towards making available essential drugs in low- and middle-income countries

200 out of 500 combinations examined have been found irrational: Govt sources

This is part of the government's plan to ban Fixed Dose Combinations as recommended by the Chandrakant Kokate committee report

Demonetisation impact: Global trade fair seen as lacking past allure

The mega fair is an indicator of the country's business sentiment and the overall mood of the people

NPPA brings 540 drugs under price control; revises prices of 40

The National Pharmaceutical Pricing Authority is an independent regulator of prices in the pharmaceutical sector

India seeks inputs from 200 countries for amending drugs and cosmetics act

Drug controller is rest assured that only recommendations will be taken and the will ensure that laws do not harm the medium and small players in India

Panel says only low-risk medicines can be sold online

Govt working to form a centralised portal

Sweet pill for Indian pharma as Donald 'Trumps' Clinton

As a part of his seven-point health care agenda, Trump had said this would allow consumers access to better drugs made abroad

Lupin's net profits up 57.8% to Rs 662.2 crore

Lupin's India formulation sales grew by 12.1% to Rs 995.8 cr during Q2 FY2017 as compared to Rs 888.1 cr during Q2 FY2016

Trump win might mean opportunities for Indian pharma

Trump had proposed to lift entry barriers for drug makers that offer safe, reliable and cheaper products

Consultative committee on e-pharmacies recommend low risk drugs sale

Recommendation to continue until e-pharmacies prove their worth

Access to medicines a problem in India: Annaswamy Vaideesh, GSK India MD

Vaideesh says that the real problem is not capping of drug prices, but in the method adopted in revising prices